Federation des caisses Desjardins du Quebec’s Oric Pharmaceuticals ORIC Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65K	Buy	6,000 +3,000	+100%	+$27.2K	﹤0.01%	1857
2026 Q1	$38K	Sell	3,000 -1,000	-25%	-$11.4K	﹤0.01%	1936
2025 Q4	$32.7K	Buy	4,000 +2,000	+100%	+$23K	﹤0.01%	1929
2025 Q3	$24K	Hold	2,000	–	–	﹤0.01%	2000
2025 Q2	$20.3K	Hold	2,000	–	–	﹤0.01%	1808
2025 Q1	$11.2K	Hold	2,000	–	–	﹤0.01%	1926
2024 Q4	$16.1K	Hold	2,000	–	–	﹤0.01%	1736
2024 Q3	$20.5K	Buy	+2,000	New	+$19.8K	﹤0.01%	1662

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federation des caisses Desjardins du Quebec's ORIC Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Oric Pharmaceuticals (ORIC) stake by 100% in Q2 2026, buying an estimated $27.2K and bringing the position to 6,000 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Federation des caisses Desjardins du Quebec first reported a position in ORIC in Q3 2024 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Federation des caisses Desjardins du Quebec held 6,000 shares of Oric Pharmaceuticals worth $65K as of Q2 2026.
Federation des caisses Desjardins du Quebec bought 3,000 Oric Pharmaceuticals shares in Q2 2026, an estimated $27.2K.
Oric Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1857 holding.
Federation des caisses Desjardins du Quebec first reported a position in Oric Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.